Activists urge Eurasian states to order more affordable medicines, after HIV patent is dropped
Call to action NewsAbbVie has waived its patent rights for HIV drug, lopinavir/ritonavir (LPV/r), in many parts of the world, including for the...
AbbVie has waived its patent rights for HIV drug, lopinavir/ritonavir (LPV/r), in many parts of the world, including for the...